News Monash IVF Group Limited

Stocks

MVF

AU000000MVF3

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 07:10:25 21/07/2026 BST			5-day change	1st Jan Change
0.6800 ^AUD	+0.74%		-4.23%	-7.48%

07-12	Monash IVF Group Acknowledges ASX Listing Rule Breach	MT
06-16	Monash IVF Group Signs Supply Deal With Memphasys; Shares Down 3%	MT

All News

Mentions Relevance

07-12	Monash IVF Group Acknowledges ASX Listing Rule Breach	MT
06-16	Monash IVF Group Signs Supply Deal With Memphasys; Shares Down 3%	MT
06-12	Monash IVF Group Still Expected to Lose Australian Market Share in Fiscal 2026, Jefferies Says	MT
06-12	Monash IVF Group Cuts Fiscal Year 2026 Underlying Net Profit After Tax Guidance	MT
05-20	Monash IVF appoints Fleur Cattrall as inaugural Chief Medical Officer	RE
05-20	Monash IVF Group Appoints Chief Medical Officer	MT
05-19	Monash Ivf Group Limited Appoints Dr Fleur Cattrall as Inaugural Chief Medical Officer	CI
04-20	WHSP Holdings Limited and Genesis Capital cancelled the acquisition of 80.4% stake in Monash IVF Group Limited.	CI
04-20	Monash IVF Group rejects revised non-binding indicative proposal	RE
04-20	Monash IVF Group Rejects Revised Takeover Proposal	MT
04-20	Australia's Monash IVF rejects second takeover offer from consortium; shares slide	RE
04-20	Australia's Monash IVF rejects another takeover offer from consortium	RE
04-13	Australia's Monash IVF gets higher buyout offer, valuing it at $246 million	RE
04-13	Monash IVF Group Receives Sweetened Takeover Offer From Genesis, Soul Patts Consortium; Shares Climb 19%	MT
04-13	Monash IVF Group gets revised NBIO to acquire co	RE
03-26	Monash IVF Group appoints Birol Akdogan as interim CFO	RE
03-25	Monash IVF Group Appoints Interim CFO	MT
03-25	Monash IVF Group Limited Appoints Birol Akdogan as Interim Chief Financial Officer, Effective 26 March 2026	CI
03-04	Monash IVF Group Limited, H1 2026 Earnings Call, Feb 26, 2026
02-25	Monash IVF Group Limited Announces Ordinary Fully Franked Interim Dividend for the Period Ended December 31, 2025, Payable on 10 April 2026	CI
02-25	Monash IVF Group Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
01-30	Monash IVF Group Limited Appoints Rebecca Dean as Company Secretary and General Counsel Effective March 4, 2026	CI
01-27	Monash IVF Group Limited Announces Resignation of Malik Jainudeen as Chief Financial Officer, Effective End of April 2026	CI
01-27	Monash IVF Group Limited Announces Resignation of Malik Jainudeen as Company Secretary, Effective End of April 2026	CI
01-27	Monash IVF Group says CFO Malik Jainudeen resigns	RE